1[1]Abe J, Kotzin BL, Jujo K, et al. Selective expansion of T cells expressing T-cell receptor viariable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Sci USA,1992,89(9):4066
2[2]Rowley AH. The etiology of Kawasaki disease: superantigen or conventional antigen? Pediatr Infect Dis J,1999,18:69
3[3]Akagi T, Ogawa S, Ino T, et al. Catheter interventional treatment in Kawasaki disease: a report from the Japanese Pediatric Interventional Cardiology Investigation Group. J Pediatr, 2000,137:181
4[4]Kuramochi Y, Ohkubo T, Takechi N, et al. Feasibility of percutaneous transluminal coronary angioplasty with Kawasaki disease as an early management strategy. Pediatr Cardiol, 2001,22:183
5Holman RC, Cures AT, Belay ED, et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics, 2003, 112:495-501.
6Shulman ST, Melish M, lnoue O, et al. Immunoglobulin allotypic markers in Kawasaki disease. J Pediatr,1993, 122: 84-86.
7Burns JC, Shimizu C, Shike H, et al. Candidate genes for susceptibility to Kawasaki Disease: analysis of preferentially transmitted alleles inpatient/parent triads. Pediatr Res, 2003,53:325A
8Leung DY, Meissner HC, Fulton DR, et al. Toxic shock syndrome toxin-secreting staphylococcus aureus in Kawasaki syndrome. Lancet, 1993,342: 1385-1388.
9Leung DY, Meissner HC, Shulman ST, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.J Pediatr, 2002,140:742 -746.
10Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med, 1991, 324: 1633-1639.
